Read more

Member of the PFMD Strategic Advisory Board (SAB). A formally constituted group of experts who provide high quality, objective advice to the executive team and PFMD team in areas of strategic importance.

People

Andrew Garvey

Global Patient Advocacy Lead

GlaxoSmithKline

JT

Jeremy Taylor

Chief Executive

London, United Kingdom

National Voices

BR

Bertrand RENAUD

France

Servier

JN

Jan Nissen

VP Patient Innovation & Engagement

North Wales, United States

Merck Sharp & Dohme (MSD)

RC

Richie Castles

United Kingdom

MD

Maria Dutarte

EUPATI

Pledge icon

Barbara Lopez Kunz

Global Chief Executive

Drug Information Association (DIA)

DN

Doug Noland

Astellas

Laure Delbecque

Research Scientist - Patient Focused Outcomes Center of Expertise

Belgium

Pharmerit International / Lilly

Amy Ohmer

Director, International Children's Advisory Network

Pinckney, United States

International Children's Advisory Network (iCAN)

Sarah Krug

Executive Director

New York, United States

CANCER101 / Society for Participatory Medicine

Pledge icon

Muriël Marks

Member of the Board of Directors/Executive Director

Netherlands

The World Alliance of Pituitary Organizations (WAPO)

Pledge icon

Sheila Khawaja

Patient engagment advisor | co-creator | catalyser

San Canzian dIsonzo, Italy

The World Alliance of Pituitary Organizations (WAPO)

Pledge icon

Laura Evans

Sheffield, United Kingdom

NIHR Sheffield Biomedical Research Centre (BRC)

BP

Berkeley Phillips

Country Medical Director Pfizer UK

Pfizer

Karlin Schroeder

Associate Vice President, Community Engagement

Parkinson's Disease Foundation

Pledge icon

Natasha Ratcliffe

Research Involvement Manager

London, United Kingdom

Parkinsons UK

Pledge icon

Michaela Dinboeck

Global Head Patient Engagement Center of Excellence

Basel, Switzerland

Novartis

Pledge icon
BH

Beverly Harrison

Titusville, United States

Janssen - Johnson & Johnson